First Time Loading...

MorphoSys AG
XETRA:MOR

Watchlist Manager
MorphoSys AG Logo
MorphoSys AG
XETRA:MOR
Watchlist
Price: 69.4 EUR 0.51% Market Closed
Updated: May 18, 2024

MorphoSys AG
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MorphoSys AG
Interest Income Expense Peer Comparison

Comparables:
BNTX
CVAC
IMTX
BIO
FYB

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
MorphoSys AG
XETRA:MOR
Interest Income Expense
€42.5m
CAGR 3-Years
22%
CAGR 5-Years
134%
CAGR 10-Years
47%
BioNTech SE
NASDAQ:BNTX
Interest Income Expense
€313.5m
CAGR 3-Years
N/A
CAGR 5-Years
121%
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Interest Income Expense
€14.2m
CAGR 3-Years
N/A
CAGR 5-Years
53%
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Interest Income Expense
€4.7m
CAGR 3-Years
-24%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Interest Income Expense
-€35.2m
CAGR 3-Years
-12%
CAGR 5-Years
-42%
CAGR 10-Years
-19%
Formycon AG
XETRA:FYB
Interest Income Expense
€14.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MorphoSys AG's Interest Income Expense?
Interest Income Expense
42.5m EUR

Based on the financial report for Mar 31, 2024, MorphoSys AG's Interest Income Expense amounts to 42.5m EUR.

What is MorphoSys AG's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
47%

The average annual Interest Income Expense growth rates for MorphoSys AG have been 22% over the past three years , 134% over the past five years , and 47% over the past ten years .